Leishmaniasis
Research on leishmaniasis described by scientists at University Peruana Cayetano Heredia
Published in Medicine and Law Weekly, July 13th, 2007
Scientists discuss in "Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis" new findings in leishmaniasis. "Few therapeutic options are available for mucocutaneous leishmaniasis (MCL). We conducted a randomized open trial to evaluate the efficacy, safety, and tolerance of parenteral aminosidine sulphate (AS) 14 mg/kg/d for 21 days compared with intravenous meglumine antimonate (MA) 20 mg/kg/d for 28 days in patients with moderate MCL in Cuzco, Peru," investigators in Lima, Peru report.
"Cure was defined as complete healing with re-epithelialization within 1 year of follow-up. The trial was stopped after 38 patients were enrolled (17 in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Cancer Quality of Care
Investigators at Roswell Park Cancer Institute zero in on cancer quality of care - Epidemiology
Scientists at Cornell University describe research in epidemiology - Immunization
Report summarizes immunization study findings from Centers for Disease Control and Prevention - Life Sciences
Findings from University of New Hampshire, Research Center advance knowledge in life sciences - Life Sciences
New life sciences study results from Urban Institute described - Life Sciences
Research from Samford University provides new data on life sciences - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
